Enhancing the QUAlity and Transparency Of health Research

Blog Archives

07/12/2023 Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement 24/10/2023 Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance 22/03/2023 STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement 04/01/2023 Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension 22/06/2021 Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement 30/04/2021 CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration 09/09/2020 Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension 22/06/2020 The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design 21/02/2020 Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement 10/10/2019 CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM): Recommendations, explanation and elaboration

Blog archives

Latest guest blogger